• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET 360 ULTRA 2MM X 3CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET 360 ULTRA 2MM X 3CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Catalog Number M0035422030
Medical Device Problem Code Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/14/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Due to the automated mes (manufacturing execution system) there are controls in the manufacturing process to ensure the product met specifications upon release.During visual inspection, the subject main coil was seen to be detached.There were no anomalies noted to the main coil.During functional inspection main coil failed/unable to detach functional test ¿ fail, the main coil was returned detached.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported complaint was not confirmed based on analysis.The device failed to meet specifications when received for complaint investigation based on the analyzed anomalies noted to the device.Additional information provided by the customer, the device was prepared for use as per the direction for use (dfu).There was no damage noted to the packaging prior to opening the packaging.The device was confirmed to be in good condition during preparation/ prior to use on the patient.Continuous flush was set up and maintained throughout the clinical procedure.When the 7th coil was positioned in the target site and detachment was attempted using in-zone.However, the coil could not be detached.After repeating "long beep twice, confirm the failure of detachment under fluoroscopy, and re-positioning the coil again" three times, the coil was removed from the sl-10 hub.During analysis the main coil was returned detached.There were no other anomalies noted.Based on the review of all available information, an assignable cause of not confirmed will be assigned to the as reported (ar) 'main coil failed/unable to detach as the defect was not confirmed, the main coil was already detached.An assignable cause of procedural factors will be assigned to as analyzed (aa) ¿main coil prematurely detached/separated during use¿ as these defects are associated with a product that met stryker design and manufacturing specifications and was used in accordance with the dfu, but performance was limited due to procedural and/or anatomical factors during use.
 
Event or Problem Description
The coil (subject device) was returned for analysis, and it was discovered that the main coil (subject device) was returned detached.The subject device was replaced, and the procedure was completed successfully.No clinical consequences were reported to the patient due to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET 360 ULTRA 2MM X 3CM
Common Device Name
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key23324127
Report Number3008881809-2025-00563
Device Sequence Number21485914
Product Code HCG
UDI-Device Identifier04546540675835
UDI-Public(01)04546540675835(17)270108(10)23404908R
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K242243
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 10/17/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberM0035422030
Device Lot Number23404908R
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/29/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 09/24/2025
Initial Report FDA Received Date10/17/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/10/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
EXCELSIOR SL-10 MICROCATHETER (STRYKER); INZONE DETACHMENT DEVICE (STRYKER)
Patient SexUnknown
-
-